Targeted cancer therapies have transformed modern oncology treatment. One such important medicine is SORANIB200 Tablets, widely used in the treatment of advanced cancers. At Unnati Pharmax, we specialize in the export of SORANIB200 from India, supplying high-quality pharmaceutical products to international markets.
This blog provides complete and accurate information about SORANIB200, including its uses, working mechanism, dosage, side effects, and export availability.
What is SORANIB200?
SORANIB200 is a branded formulation of Sorafenib 200 mg, a tyrosine kinase inhibitor (TKI). It works by blocking cancer cell growth and reducing blood supply to tumors.
Because of its targeted action, SORANIB200 is commonly prescribed for advanced and metastatic cancers.
Uses of SORANIB200 Tablets
SORANIB200 Tablets are mainly used for the treatment of:
-
Hepatocellular Carcinoma (Liver Cancer)
-
Advanced Renal Cell Carcinoma (Kidney Cancer)
-
Differentiated Thyroid Cancer
Therefore, SORANIB200 plays a critical role in long-term cancer management.
How Does SORANIB200 Work?
SORANIB200 contains Sorafenib, which inhibits multiple protein kinases involved in:
-
Tumor cell proliferation
-
Angiogenesis (blood vessel formation)
As a result, cancer growth slows down and tumor progression is controlled effectively.
Dosage and Administration
-
Standard dosage: 200 mg tablets, usually taken twice daily
-
Taken orally with water
-
Should be consumed without high-fat meals
β οΈ Important: Dosage must be decided by an oncologist based on patient condition.
Possible Side Effects
Some patients may experience side effects such as:
-
Fatigue
-
Hand-foot skin reaction
-
Diarrhea
-
High blood pressure
-
Hair thinning
-
Loss of appetite
However, most side effects are manageable with medical supervision.
Precautions and Warnings
Before using SORANIB200, patients should inform their doctor if they have:
-
Heart disease
-
Liver problems
-
High blood pressure
-
Bleeding disorders
Additionally, pregnant and breastfeeding women should avoid this medicine.
Why Choose Unnati Pharmax for SORANIB200 Export?
Unnati Pharmax is a reliable pharmaceutical exporter from India, known for quality and compliance.
Our Key Advantages
-
WHO-GMP certified sourcing
-
Competitive export pricing
-
Secure packaging for global transit
-
Complete export documentation
-
Timely worldwide delivery
As a result, international buyers trust Unnati Pharmax for oncology medicine exports.
Global Export of SORANIB200 Tablets
Unnati Pharmax exports SORANIB200 Tablets to:
-
Africa
-
Middle East
-
Southeast Asia
-
CIS countries
-
Latin America
Furthermore, we provide regulatory and logistics support for smooth import processes.
Frequently Asked Questions (FAQs)
1. What is SORANIB200 used for?
SORANIB200 is used to treat liver cancer, kidney cancer, and thyroid cancer.
2. Is SORANIB200 a chemotherapy drug?
No. SORANIB200 is a targeted therapy, not traditional chemotherapy.
3. Can SORANIB200 be exported from India?
Yes. Unnati Pharmax exports SORANIB200 with all required legal and regulatory documents.
4. How should SORANIB200 be stored?
Store at room temperature, away from moisture and direct sunlight.
5. Why buy SORANIB200 from Unnati Pharmax?
Because we offer authentic products, competitive pricing, and reliable global supply.
Conclusion
In conclusion, SORANIB200 Tablets are an effective targeted treatment option for multiple advanced cancers. Choosing a trusted supplier is essential for quality and safety.